Subscribe to Newsletter
Diagnostics Biochemistry and molecular biology, Genetics and epigenetics

Molecular Diagnostics on the Rise

What’s the fastest-growing field in the laboratory medicine industry? If you ask five different people, you may well get five different answers – but one thing is for sure: there is an escalating demand for competent and accurate diagnostic methods. And for those who desire the most precise and personalized medicine possible, molecular diagnostics are key.

The expansion of the molecular pathology industry won’t be solely down to patient demand, though. Market researchers have also seen widespread product acceptance for applications including infection identification, patient stratification, drug regimen selection and therapeutic monitoring, and more. Because any error in diagnosis or treatment can have severe repercussions, pathologists and laboratory medicine professionals need accurate, safe, and dependable diagnostic tools – and this is where molecular diagnostics has the opportunity to shine.

Genetic disorders and infectious diseases must be diagnosed early and accurately, not only to provide efficient treatment, but also because late detection can give rise to further complications. In terms of the reliability and rapid response time required for early intervention, traditional diagnostic approaches fall significantly short. As a result, the molecular diagnostics market is expecting significant growth (1).

Molecular Diagnostics in 2024

Projected market share for molecular diagnostics: ≥US$12.5 billion

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. S Ugalmugale, “Molecular Diagnostics Market size to exceed $12.5 bn by 2024” (2018). Available at:
About the Author
Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine